富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/12/30 | 日証協 | 306,355株 | +67.27% | 190,200株 | +137.75% | 407,653株 | +0.05% | 73,815株 | -23.7% |
2022/12/23 | 日証協 | 183,155株 | +0.34% | 80,000株 | +1233.33% | 407,447株 | +0.47% | 96,739株 | +315.46% |
2022/12/16 | 日証協 | 182,530株 | 0% | 6,000株 | +475.82% | 405,530株 | +1.61% | 23,285株 | -34.65% |
2022/12/09 | 日証協 | 182,530株 | -0.11% | 1,042株 | -70.69% | 399,123株 | +2.89% | 35,633株 | +456.68% |
2022/12/02 | 日証協 | 182,732株 | -1.88% | 3,555株 | +1677.5% | 387,922株 | -0.15% | 6,401株 | +77.81% |
2022/11/18 | 日証協 | 187,332株 | -1.21% | 4,877株 | -80.62% | 390,522株 | +0.8% | 14,383株 | -57.3% |
2022/11/11 | 日証協 | 189,632株 | -0.9% | 25,167株 | +16.27% | 387,431株 | +1.23% | 33,680株 | +1.48% |
2022/11/04 | 日証協 | 191,355株 | +6.19% | 21,645株 | +7714.08% | 382,731株 | +3.77% | 33,190株 | +577.35% |
2022/10/28 | 日証協 | 180,200株 | -6.83% | 277株 | +177% | 368,831株 | -1.52% | 4,900株 | -42.96% |
2022/10/21 | 日証協 | 193,400株 | -2.52% | 100株 | -99.49% | 374,531株 | -3.38% | 8,590株 | -36.28% |
2022/10/14 | 日証協 | 198,400株 | +308.23% | 19,800株 | -87% | 387,631株 | +22.19% | 13,480株 | -86.15% |
2022/10/07 | 日証協 | 48,600株 | -48.85% | 152,300株 | +151.26% | 317,231株 | +132.96% | 97,304株 | -66.1% |
2022/09/30 | 日証協 | 95,014株 | +65.82% | 60,614株 | +910.23% | 136,172株 | -58.11% | 287,047株 | +843.67% |
2022/09/22 | 日証協 | 57,300株 | -2.55% | 6,000株 | +5900% | 325,040株 | +0.94% | 30,418株 | -6.96% |
2022/09/16 | 日証協 | 58,800株 | -32.57% | 100株 | -99.72% | 322,024株 | -4.87% | 32,695株 | -36.27% |
2022/09/09 | 日証協 | 87,200株 | +22.24% | 35,300株 | +315.29% | 338,525株 | +0.68% | 51,305株 | +100.4% |
2022/09/02 | 日証協 | 71,334株 | -2.73% | 8,500株 | +70% | 336,229株 | +2.96% | 25,601株 | +139.15% |
2022/08/26 | 日証協 | 73,339株 | -12.18% | 5,000株 | +61.29% | 326,548株 | -0.49% | 10,705株 | +22.09% |
2022/08/19 | 日証協 | 83,514株 | -5.76% | 3,100株 | -80.38% | 328,150株 | -0.55% | 8,768株 | -74.51% |
※株式分割は考慮していませんのでご注意ください。
Page Top